Cargando…
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Following the first reports of coronavirus disease-19 (COVID-19) by China to the World Health Organization (WHO) on 31st December 2019, more than 4,302,774 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cases have been reported by authorities in 212 countries and territories by 1...
Autores principales: | D'Cruz, Roshan J., Currier, Arthur W., Sampson, Valerie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287038/ https://www.ncbi.nlm.nih.gov/pubmed/32582718 http://dx.doi.org/10.3389/fcell.2020.00468 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications
por: Yu, Shijia, et al.
Publicado: (2020) -
ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication
por: Qu, Yafei, et al.
Publicado: (2021) -
The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells
por: Eiro, Noemi, et al.
Publicado: (2020) -
Epitranscriptomics of SARS-CoV-2 Infection
por: Izadpanah, Amin, et al.
Publicado: (2022) -
The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients
por: Tang, Bufu, et al.
Publicado: (2020)